With the PTAB soon to issue institution decisions on the controversial IPR petitions from the Coalition for Affordable Drugs and Ferro Ferrum Capital, patent owners have hit back through sanctions and additional discovery, and a complaint for attempted extortion
Unlock this content.
The content you are trying to view is exclusive to our subscribers.
Firms reflect on how they’re managing their design patent practices as brands seek to enforce their rights at the Northern District of Illinois and beyond